Clinical Trial Update: CHFR Methylation Status Esophageal Cancer Study [Phase 2]

View source ↗

Summary

Phase 2 trial investigating CHFR methylation status in esophageal cancer; the study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Esophageal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-08-30